Diversified Healthcare Trust - 6.25% NT REDEEM 01/02/2046 USD 25 (DHCNL) has a ROE of -19.76%, below the Finance sector average of 16.71%.
Get informed when a big investor buys or sells
+ Follow-19.76%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Diversified Healthcare Trust - 6.25% NT REDEEM 01/02/2046 USD 25 posts a ROE of -19.76%. That is below the Finance sector average of 16.71%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
For Finance stocks, a ROE near 16.71% is typical. Diversified Healthcare Trust - 6.25% NT REDEEM 01/02/2046 USD 25's -19.76% is lower that level. That is roughly 218.3% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
Diversified Healthcare Trust - 6.25% NT REDEEM 01/02/2046 USD 25's ROE moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -19.76%; use YoY and peer views to separate noise from signal.
Context for DHCNL's ROE usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 16.71%), and (3) consistency with growth and profitability. This page covers the first two; Diversified Healthcare Trust - 6.25% NT REDEEM 01/02/2046 USD 25's other metric pages and overview cover the third.
Judging Diversified Healthcare Trust - 6.25% NT REDEEM 01/02/2046 USD 25 against Finance peers is usually better than using a market-wide rule of thumb. Business models inside Finance are more comparable, which makes gaps in ROE easier to interpret. Start with -19.76% here, then scan peer and history charts to see if the gap is persistent.